Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in liposomal drug delivery systems.

N Maurer1, D B Fenske, P R Cullis

  • 1Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada. nmaurer@inexpharm.com

Expert Opinion on Biological Therapy
|December 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 60-year evolution of lipid nanoparticles for nucleic acid delivery.

Nature reviews. Drug discovery·2024
Same author

Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2022
Same author

Structural Properties of Inverted Hexagonal Phase: A Hybrid Computational and Experimental Approach.

Langmuir : the ACS journal of surfaces and colloids·2020
Same author

Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide.

Nanomedicine : nanotechnology, biology, and medicine·2019
Same author

Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.

Nanoscale·2019
Same author

Lipid nanoparticle delivery systems for siRNA-based therapeutics.

Drug delivery and translational research·2015
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
Same journal

Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective.

Expert opinion on biological therapy·2026
See all related articles

Liposomes are advanced drug delivery systems, improving cancer treatment efficacy and reducing toxicity. This review highlights their success with small molecules and potential for genetic drugs.

Area of Science:

  • Biotechnology
  • Pharmaceutics
  • Nanomedicine

Background:

  • Liposomes are leading systemic drug delivery vehicles, with approved formulations and ongoing clinical trials.
  • Liposomal drug delivery offers reduced toxicity and enhanced efficacy for treating cancer and other critical diseases.
  • Understanding liposome mechanisms, like preferential accumulation at disease sites, drives therapeutic advantages.

Purpose of the Study:

  • To review the field of liposomal drug delivery.
  • To summarize the successes of liposomes in delivering small molecule drugs.
  • To explore the development of liposomes as carriers for genetic drugs.

Main Methods:

  • Literature review of liposomal drug delivery systems.
  • Analysis of clinical trial data for liposomal formulations.

Related Experiment Videos

  • Examination of liposome-based genetic drug delivery strategies.

    • Main Results:

    • Liposomes are established for systemic administration, showing clinical approval and trial success.
    • Therapeutic benefits include reduced toxicity and enhanced efficacy, particularly in oncology.
    • Liposomes demonstrate preferential accumulation at disease sites like tumors and inflammation.
    • Emerging applications include liposome-based delivery of genetic drugs (antisense oligonucleotides, plasmids).

    Conclusions:

    • Liposomes have proven successful for small molecule drug delivery.
    • The established success of liposomes is being leveraged for advanced genetic drug delivery systems.
    • Liposomal technology holds significant promise for future therapeutic applications, including gene therapy.